(Q43194568)

English

Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases

scientific article published on 14 January 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

1 reference

based on heuristic

inferred from title

Kazuaki Chayama

13

object named as

Kazuaki Chayama

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

2

object named as

Hiroshi Aikata

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Tomokazu Kawaoka

4

object named as

Tomokazu Kawaoka

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Yoshiiku Kawakami

8

object named as

Yoshiiku Kawakami

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Akira Hiramatsu

7

object named as

Akira Hiramatsu

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Shoichi Takahashi

9

object named as

Shoichi Takahashi

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

author name string

Yoshio Katamura

1

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Yuki Kimura

3

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Shintaro Takaki

5

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Koji Waki

6

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Masaki Ishikawa

10

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Masashi Hieda

11

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Hideaki Kakizawa

12

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

publication date

14 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

1117-1122

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Management of hepatocellular carcinoma in Japan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Natural history of untreated nonsurgical hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Clinical features of hepatocellular carcinoma with extrahepatic metastases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Extrahepatic spread from hepatocellular carcinoma: who are candidates for aggressive anti-cancer treatment?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Combination therapy of oral fluoropyrimidine anticancer drug S-1 and interferon alpha for HCC patients with extrahepatic metastases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06110.X

21 January 2018

Identifiers

10.1111/J.1440-1746.2009.06110.X

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43194568&oldid=1983278521"